Radiomics Nomogram with Added Nodal Features Improves Treatment Response Prediction in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study-Reference-Cited by-同舟云学术

Radiomics Nomogram with Added Nodal Features Improves Treatment Response Prediction in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study

Published:2023-09-27 Issue:13 Volume:30 Page:8231-8243
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Li Kunwei,Zhang Shuaitong,Hu Yi,Cai Aiqun,Ao Yong,Gong Jun,Liang Mingzhu,Yang Songlin,Chen Xiangmeng,Li Man,Tian Jie,Shan Hong

Funder

National Natural Science Foundation of China

Department of Science and Technology of Guangdong Province to the Guangdong Provincial Key Laboratory of Biomedical Imaging

Medical Research Foundation of Guangdong Province

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-14253-1.pdf

Reference33 articles.

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

2. Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014;371(26):2499–509. https://doi.org/10.1056/NEJMra1314530.

3. NCCN clinical practice guidelines: Esophageal and esophagogastric junction cancers. 2022. Available at: https://www.nccn.org/professionals/physician_gls/default.aspx#site. Accessed 27 Jan 2023.

4. Yang H, Liu H, Chen Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized. Open-Label Clinical Trial J Clin Oncol. 2018;36(27):2796–803. https://doi.org/10.1200/JCO.2018.79.1483.

5. Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–8. https://doi.org/10.1016/S1470-2045(15)00040-6.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Learning for Automatic Gross Tumor Volumes Contouring in Esophageal Cancer Based on Contrast-Enhanced Computed Tomography Images: A Multi-Institutional Study;International Journal of Radiation Oncology*Biology*Physics;2024-08

2. Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies;Hematology/Oncology Clinics of North America;2024-06

3. The molecular characteristics could supplement the staging system of pT2/T3N0M0 esophageal squamous cell carcinoma: a translational study based on a cohort with over 20 years of follow-up;Cancer Cell International;2024-03-30

4. LOMIA-T: A Transformer-based LOngitudinal Medical Image Analysis framework for predicting treatment response of esophageal cancer;2024-03-30

5. ASO Author Reflections: Can Nodal Features Improve Treatment Response Prediction in Esophageal Cancer?;Annals of Surgical Oncology;2023-09-20